These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 32623490)

  • 1. Genetic risks of schizophrenia identified in a matched case-control study.
    Oishi K; Niitsu T; Kanahara N; Sato Y; Iwayama Y; Toyota T; Hashimoto T; Sasaki T; Takase M; Shiina A; Yoshikawa T; Iyo M
    Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):775-781. PubMed ID: 32623490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
    Oishi K; Kanahara N; Takase M; Oda Y; Nakata Y; Niitsu T; Ishikawa M; Sato Y; Iyo M
    PLoS One; 2018; 13(11):e0207133. PubMed ID: 30408108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
    Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
    Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
    Dubertret C; Bardel C; Ramoz N; Martin PM; Deybach JC; Adès J; Gorwood P; Gouya L
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):492-9. PubMed ID: 20138949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
    Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.
    Srivastava V; Deshpande SN; Thelma BK
    Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis.
    Yao J; Pan YQ; Ding M; Pang H; Wang BJ
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):1-13. PubMed ID: 25504812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.
    Matsuzaka CT; Christofolini D; Ota VK; Gadelha A; Berberian AA; Noto C; Mazzotti DR; Spindola LM; Moretti PN; Smith MAC; Melaragno MI; Belangero SI; Bressan RA
    Braz J Psychiatry; 2017; 39(4):302-308. PubMed ID: 28273278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population.
    Dmitrzak-Weglarz M; Rybakowski JK; Slopien A; Czerski PM; Leszczynska-Rodziewicz A; Kapelski P; Kaczmarkiewicz-Fass M; Hauser J
    Neuropsychobiology; 2006; 53(1):46-50. PubMed ID: 16397404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.
    Kukshal P; Kodavali VC; Srivastava V; Wood J; McClain L; Bhatia T; Bhagwat AM; Deshpande SN; Nimgaonkar VL; Thelma BK
    J Psychiatr Res; 2013 Nov; 47(11):1615-22. PubMed ID: 23932573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association of close homologue of L1 gene polymorphism rs2272522 with schizophrenia in Qatar.
    Shaltout TE; Alali KA; Bushra S; Alkaseri AM; Jose ED; Al-Khainji M; Saleh R; Salama Dahir A; Shaltout H; Al-Abdullah M; Rizk NM
    Asia Pac Psychiatry; 2013 Mar; 5(1):17-23. PubMed ID: 23857787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis.
    Zhang C; Zhang J; Fan J; Cheng W; Du Y; Yu S; Fang Y
    Am J Med Genet B Neuropsychiatr Genet; 2014 Oct; 165B(7):564-71. PubMed ID: 25073965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia.
    Khodayari N; Garshasbi M; Fadai F; Rahimi A; Hafizi L; Ebrahimi A; Najmabadi H; Ohadi M
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):10-2. PubMed ID: 15274029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia.
    Zhu F; Yan CX; Wang Q; Zhu YS; Zhao Y; Huang J; Zhang HB; Gao CG; Li SB
    Brain Res; 2011 Oct; 1420():106-13. PubMed ID: 21955727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.
    Lochman J; Balcar VJ; Sťastný F; Serý O
    Psychiatry Res; 2013 Jan; 205(1-2):7-12. PubMed ID: 22940547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-locus association study of schizophrenia susceptibility genes with a posterior probability method.
    Sun X; Jia Y; Zhang X; Xu Q; Shen Y; Li Y
    Sci China C Life Sci; 2005 Jun; 48(3):263-9. PubMed ID: 16092759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
    Okochi T; Ikeda M; Kishi T; Kawashima K; Kinoshita Y; Kitajima T; Yamanouchi Y; Tomita M; Inada T; Ozaki N; Iwata N
    Schizophr Res; 2009 May; 110(1-3):140-8. PubMed ID: 19329282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia.
    Zhang C; Fang Y; Xie B; Cheng W; Du Y; Wang D; Yu S
    Psychiatry Res; 2010 May; 177(3):350-3. PubMed ID: 20382433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.